ANTIBODY-EXATECAN CONJUGATES

The present invention concerns an antibody-drug conjugate, having structure (1) wherein AB is an antibody; L1 and L2 are linkers; w is 0 or 1; Z is a connecting group obtained by a metal-free click reaction or by thiol ligation; each R17 is individually an amino acid side chain; n is an integer in the range of 1 - 5; A is a 5- or 6-membered aromatic or heteroaromatic ring; x is an integer in the range of 1 - 8; R21 is selected from H, R22, C(0)0H and C(0)R22, wherein R22 is C1 - C24 (hetero)alkyl groups, C3 - C10 (hetero)cycloalkyl groups, C2 - C10 (hetero)aryl groups, C3 - C10 alkyl(hetero)aryl groups and C3 - C10 (hetero)arylalkyl groups, which optionally substituted and optionally interrupted by one or more heteroatoms selected from O, S and NR23 wherein R23 is independently selected from the group consisting of hydrogen and C1 - C4 alkyl groups..

Medienart:

Patent

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Europäisches Patentamt - (2022) vom: 24. März Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Beteiligte Personen:

HOOGENBOOM JORIN [VerfasserIn]
VAN SCHAIK ARNOLDUS JACOBUS [VerfasserIn]
POPAL SORRAYA [VerfasserIn]
DE BEVER LAUREEN [VerfasserIn]
WIJDEVEN MARIA ANTONIA [VerfasserIn]
VAN GEEL REMON [VerfasserIn]
HURKMANS INGE CATHARINA JOSEPHINA [VerfasserIn]
VAN DE SANDE PETER [VerfasserIn]
VAN BERKEL SANDER SEBASTIAAN [VerfasserIn]
VAN DELFT FLORIS LOUIS [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2022-03-24, Last update posted on www.tib.eu: 2023-11-01, Last updated: 2023-11-10

Patentnummer:

WO2022058395

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA013163450